S20-006 Use of Focal Adhesion Kinase Inhibitors To Improve the Quality and Appearance of Split Thickness Skin Grafts A team of researchers at Stanford have developed a hydrogel that delivers a scar-reducing focal adhesion kinase inhibitor (FAK-I) to skin grafts and donor sites. Geoffrey Gurtner Kellen Chen Sun Hyung Kwon Dominic Henn